Analysts on Wall Street project that Nordson (NDSN) will announce quarterly earnings of $2.59 per share in its forthcoming report, representing an increase of 5.3% year over year. Revenues are projected to reach $733.33 million, increasing 2% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Nordson metrics that are commonly monitored and projected by Wall Street analysts.
Based on the collective assessment of analysts, 'Net Sales- Industrial Precision Solutions' should arrive at $407.64 million. The estimate suggests a change of +0.5% year over year.
The collective assessment of analysts points to an estimated 'Net Sales- Advanced Technology Solutions' of $135.17 million. The estimate suggests a change of -6.9% year over year.
Analysts expect 'Net Sales- Medical and Fluid Solutions' to come in at $197.55 million. The estimate suggests a change of +17.2% year over year.
It is projected by analysts that the 'Operating profit (loss)- Advanced Technology Solutions' will reach $25.76 million. Compared to the present estimate, the company reported $31.53 million in the same quarter last year.
According to the collective judgment of analysts, 'Operating profit (loss)- Medical and Fluid Solutions' should come in at $50.14 million. Compared to the current estimate, the company reported $48.04 million in the same quarter of the previous year.
The consensus among analysts is that 'Operating profit (loss)- Industrial Precision Solutions' will reach $136.06 million. The estimate compares to the year-ago value of $131.45 million.
View all Key Company Metrics for Nordson here>>>
Over the past month, shares of Nordson have returned -2.3% versus the Zacks S&P 500 composite's +5.2% change. Currently, NDSN carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpNordson Corporation (NDSN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
